Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IgPro10 (Privigen) in Systemic Sclerosis
NCT04138485Phase 2Withdrawn
- Sponsor
- CSL Limited
- Start
- Dec 2019
- Primary completion
- Sep 2020
- Modality
- Biologic
- Countries
- 13
01
Overview
A Phase 2 trial of IgPro10 in diffuse cutaneous systemic sclerosis (dcSSc), sponsored by CSL Limited. Planned start Dec 2019; status: withdrawn.
02
Drugs
IgPro10
03
Conditions
diffuse cutaneous systemic sclerosis (dcSSc)
Beyond the preview
Go deeper on NCT04138485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04138485.